2022 2022 Venture | Winner Winner Science Start-ups (Falling Walls Venture)

Elypta is a Swedish molecular diagnostics company focused on reducing cancer mortality through early detection. Elypta is pioneering a metabolism-based liquid biopsy and measures the GAGome as system biomarkers of tumor metabolism. Machine learning algorithms are then used to detect signatures of cancer noninvasively. Elypta is advancing a broad clinical program with core indications in multi-cancer early detection and surveillance of recurrence in renal cell carcinoma.

Events with Elypta

Mon | Nov 07, 2022 | 02.00 PM - 04.00 PM Berlin Time

Falling Walls Venture Pitches – Session 3: Health Solutions